Aetiology, ejection fraction and mortality in chronic heart failure: a mediation analysis.

heart failure

Journal

Heart (British Cardiac Society)
ISSN: 1468-201X
Titre abrégé: Heart
Pays: England
ID NLM: 9602087

Informations de publication

Date de publication:
18 Sep 2023
Historique:
received: 11 04 2023
accepted: 17 08 2023
medline: 19 9 2023
pubmed: 19 9 2023
entrez: 18 9 2023
Statut: aheadofprint

Résumé

Clinical decision making in chronic heart failure (CHF) is based primarily on left ventricular ejection fraction (LVEF), and only secondarily on aetiology of the underlying disease. Our aim was to investigate the mediating role of LVEF in the relationship between aetiology and mortality. Using data of 2056 Austrian patients with CHF (mean age 57.2 years; mean follow-up 8.8 years), effects of aetiology on LVEF and overall mortality were estimated using multivariable-adjusted linear and Cox regression models. In causal mediation analyses, we decomposed the total effect of aetiology on mortality into direct and indirect (mediated through LVEF) effects. For the analysed aetiologies (dilated (DCM, n=1009) and hypertrophic (HCM, n=89) cardiomyopathy; ischaemic (IHD, n=529) and hypertensive (HHD, n=320) heart disease; cardiac amyloidosis (CA, n=109)), the effect of LVEF on mortality was similar (HR The direct effect of aetiology on mortality dominates the indirect effect through LVEF. Therefore, clarification of aetiology is as important as measurement of LVEF.

Identifiants

pubmed: 37722825
pii: heartjnl-2023-322803
doi: 10.1136/heartjnl-2023-322803
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Josef Fritz (J)

Institute of Medical Statistics and Informatics, Medical University of Innsbruck, Innsbruck, Austria.

Katrin Belovari (K)

Department of Internal Medicine III Cardiology and Angiology, Medical University of Innsbruck, Innsbruck, Austria.

Hanno Ulmer (H)

Institute of Medical Statistics and Informatics, Medical University of Innsbruck, Innsbruck, Austria.

Marc-Michael Zaruba (MM)

Department of Internal Medicine III Cardiology and Angiology, Medical University of Innsbruck, Innsbruck, Austria.

Moritz Messner (M)

Department of Internal Medicine III Cardiology and Angiology, Medical University of Innsbruck, Innsbruck, Austria.

Maria Ungericht (M)

Department of Internal Medicine III Cardiology and Angiology, Medical University of Innsbruck, Innsbruck, Austria.

Uwe Siebert (U)

Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT - University for Health Sciences, Medical Informatics and Technology, Hall in Tirol, Austria.
Center for Health Decision Science, Departments of Epidemiology and Health Policy & Management, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Program on Cardiovascular Research, Institute for Technology Assessment and Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Frank Ruschitzka (F)

Department of Cardiology, University Heart Center, University Hospital Zurich, Zurich, Switzerland.

Axel Bauer (A)

Department of Internal Medicine III Cardiology and Angiology, Medical University of Innsbruck, Innsbruck, Austria.

Gerhard Poelzl (G)

Department of Internal Medicine III Cardiology and Angiology, Medical University of Innsbruck, Innsbruck, Austria gerhard.poelzl@tirol-kliniken.at.

Classifications MeSH